Generated June 29, 2026 at 8:33 PM ET
· Covers June 29 trading day
· 8 of 220 ready 8-Ks selected
· AI-assisted overview
The day's highest-materiality filings were dominated by major M&A transactions, including Theravance Biopharma agreeing to a $17.00/share cash-plus-CVR acquisition by Zymeworks, Digital Realty's $3.5B purchase of a Blackstone stake in Northern Virginia data centers, Martin Marietta's $13.5B acquisition of Lhoist North America, and Comcast's planned spin-off of NBCUniversal and Sky. Regulatory and clinical milestones included Minerals Technologies filing a Chapter 11 plan for BMI OldCo with a $290M charge, Larimar Therapeutics submitting a BLA module for accelerated approval of nomlabofusp in Friedreich's ataxia, and Gain Therapeutics receiving FDA IND authorization for a Phase 2 Parkinson's study. On the debt side, Acura Pharmaceuticals disclosed a loan extension and warned of a possible shutdown, while several other filings involved routine updates or lower-materiality events.
MTX
MINERALS TECHNOLOGIES INC
regulatory
negative
materiality 0.85
June 29, 2026, 5:02 PM ET
MTI files Chapter 11 plan for BMI OldCo, records $290M charge, proposes $450M talc trust
- Files Plan of Reorganization in BMI OldCo Chapter 11 cases per court deadline.
- Proposes $450M Talc Personal Injury Trust funded by non-debtor affiliates.
- MTI to record $290M charge in Q2 2026 to increase reserve for estimated costs.
TBPH
Theravance Biopharma, Inc.
M&A
positive
materiality 0.90
June 29, 2026, 6:30 AM ET
Theravance Biopharma to be acquired by Zymeworks for $17.00/share cash plus CVR
- Shareholders receive $17.00/share cash (~$929M equity value) plus a CVR for 80% of net proceeds from ampreloxetine monetization over ten years.
- Transaction represents a 22% premium to TBPH's March 3, 2026 close and 10% premium to VWAP since then.
- Merger expected to close in H2 2026, subject to shareholder vote (2/3 majority), HSR clearance, and customary conditions.
—
DIGITAL REALTY TRUST, L.P.
M&A
positive
materiality 0.85
June 29, 2026, 5:25 PM ET
Digital Realty to buy Blackstone's 64% stake in three Northern VA data centers for $3.5B
- Total consideration $3.5B ($1.2B cash + $2.3B non-voting common stock at June 29, 2026 closing price).
- Three hyperscale data centers total 288 MW IT capacity in Northern Virginia, gross value $7.8B (incl. debt and remaining capex).
- 100% leased to three investment-grade hyperscale customers; 15-year leases with 3.6% annual rent escalators; expected stabilized cap rate >6.5%.
LRMR
Larimar Therapeutics, Inc.
regulatory
positive
materiality 0.85
June 29, 2026, 6:33 AM ET
Larimar submits BLA module for nomlabofusp accelerated approval; positive open-label data in Friedreich's ataxia
- Submitted first module of rolling BLA to FDA for accelerated approval of nomlabofusp; FDA confirmed existing data appears sufficient.
- Open-label study: 100% (9/9) of participants achieved skin FXN levels >50% of healthy volunteer mean at 1 year.
- Clinical outcomes improved vs natural history: mean 1.0-point mFARS improvement vs 1.6-point worsening at 1 year.
—
ACURA PHARMACEUTICALS, INC
debt
negative
materiality 0.95
June 29, 2026, 4:16 PM ET
Acura extends loan maturity and NDA deadline with AD Pharma, warns of possible shutdown
- Received $200,000 loan from AD Pharma on June 24, 2026, bringing principal balance to $10,694,279 with accrued interest of ~$1.16M.
- Extended NDA acceptance deadline for LTX-03 from June 30, 2026 to December 31, 2026 via amendment #14 to license agreement.
- Extended maturity date of secured promissory note from June 30, 2026 to December 31, 2026 via amendment #8.
MLM
MARTIN MARIETTA MATERIALS INC
M&A
neutral
materiality 1.00
June 29, 2026, 5:27 PM ET
Martin Marietta to acquire Lhoist North America for $13.5B in cash and stock
- Total consideration $13.5B: $7B cash + $6.5B in new MLM shares (10,953,543 shares at 15-day VWAP).
- LNA Holding to receive 10,953,543 newly issued MLM shares and $7B cash.
- Transaction closing expected by Oct 31, 2026, extendable to June 15, 2027; subject to HSR and regulatory approvals.
GANX
Gain Therapeutics, Inc.
regulatory
positive
materiality 0.75
June 29, 2026, 4:21 PM ET
FDA authorizes IND for Gain Therapeutics' GT-02287, permitting Phase 2 Parkinson's study
- FDA authorized IND for GT-02287, enabling Phase 2 clinical development in Parkinson's disease with or without GBA1 mutation.
- Phase 2a study of oral GT-02287 in early Parkinson's patients planned; sites in U.S., Australia, and Europe.
- Phase 2a initiation expected in Q3 2026; Phase 1a/b were conducted in Australia.
other material
positive
materiality 1.00
June 29, 2026, 9:03 AM ET
Comcast to spin off NBCUniversal and Sky into independent public company; Cavanagh, Angelakis named CEOs
- Tax-free spin-off expected in approximately one year, subject to board approval, tax opinions, and regulatory clearances.
- Mike Cavanagh to serve as CEO of NBCUniversal; Michael Angelakis to return as CEO of Comcast post-separation.
- Brian L. Roberts will remain actively involved at both companies, working with both CEOs.